Alpha Cognition Operating Expenses 2020-2024 | ACOG
Alpha Cognition operating expenses from 2020 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Alpha Cognition Annual Operating Expenses (Millions of US $) |
2023 |
$10 |
2022 |
$14 |
2021 |
$12 |
2020 |
$6 |
2019 |
$6 |
Alpha Cognition Quarterly Operating Expenses (Millions of US $) |
2024-06-30 |
$2 |
2024-03-31 |
$4 |
2023-12-31 |
$2 |
2023-09-30 |
$3 |
2023-06-30 |
$3 |
2023-03-31 |
$2 |
2022-12-31 |
$3 |
2022-09-30 |
$3 |
2022-06-30 |
$4 |
2022-03-31 |
$3 |
2021-12-31 |
$4 |
2021-09-30 |
$3 |
2021-06-30 |
$2 |
2021-03-31 |
$2 |
2020-12-31 |
$2 |
2020-09-30 |
$2 |
2020-06-30 |
$2 |
2020-03-31 |
$1 |
2019-12-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|